Tab.Paxlovid for covid treatment

WHO nod for Pfizer’s Covid-19 antiviral pill 

eAwaz Medicine

Washington – The World Health Organization gave green light to use Pfizer Inc’s oral COVID-19 antiviral treatment in high-risk patients after an analysis of trial data by it showed the therapy dramatically cut the risk of hospitalization. The recommendation comes as thousands of people die of COVID-19 every week, despite a waning global infection rate. Of existing COVID-19 treatments, Pfizer’s PFE.N Paxlovid is by far …

Merck Ridgebacks Molnupiravir

Molnupiravir benefit outweigh the potential risks

eAwaz Medicine

Washington – Health experts say benefits of Molnupiravir – an oral antiviral pill, developed by US-based drug company Merck, and approved for treating Covid-19, outweigh the potential risks it may have in the case of high-risk patients. Molnupiravir is approved by the US FDA against Covid-19. It is approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for …